Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03393936

Recruitment Status : Active, not recruiting

First Posted : January 9, 2018

Last Update Posted : October 21, 2021

Sponsor:

Collaborator:

Shanghai Public Health Clinical Center

Information provided by (Responsible Party):

Shanghai PerHum Therapeutics Co., Ltd.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	June 30, 2022
Estimated Study Completion Date :	June 30, 2023

To Top